Update on vaccination of cattle and wildlife populations against tuberculosis

Veterinary Microbiology

Volumn 151, Issue 1-2, 2011, Pages 14-22

  Buddle, Bryce M ^a   Wedlock, D Neil ^a   Denis, Michel ^a   Vordermeier, H Martin ^b   Hewinson, R Glyn ^b  

^a AGRESEARCH GRASSLANDS   (New Zealand)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Bovine tuberculosis; Cattle; Mycobacterium bovis; Vaccine; Wildlife

Indexed keywords

BCG VACCINE; DNA VACCINE; MYCOBACTERIUM VACCINE;

ARTICLE; BOVINE TUBERCULOSIS; CATTLE; DISEASE SEVERITY; HUMAN; INFECTION PREVENTION; OPOSSUM; TUBERCULOSIS CONTROL; VACCINATION; WILDLIFE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANIMALS, WILD; BCG VACCINE; CATTLE; MYCOBACTERIUM BOVIS; TUBERCULOSIS, BOVINE; VACCINATION; VACCINES, ATTENUATED; VACCINES, DNA;

ANIMALIA; BOS; BOVINAE; MYCOBACTERIUM BOVIS;

EID: 79957509786     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.02.021     Document Type: Article

References (72)

1. Aagaard C., Dietrich J., Doherty M., Andersen P. TB vaccines: current status and future perspectives. Immunol. Cell Biol. 2009, 87:279-286.
2. Aldwell F.E., Keen D.L., Stent V.C., Thomson A., Yates G.F., de Lisle G.W., Buddle B.M. Route of BCG administration in possums affects protection against bovine tuberculosis. N. Z. Vet. J. 1995, 43:356-359.
3. Aldwell F.E., Keen D., Parlane N., Skinner M.A., de Lisle G.W., Buddle B.M. Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in possums. Vaccine 2003, 22:70-76.
4. Ballesteros C., Garrido J.M., Vicente J., Romero B., Galindo R.C., Minguijón E., Villar M., Martín-Hernando M.P., Sevilla I., Juste R., Aranaz A., de la Fuente J., Gortázar C. First data on Euasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain. Vaccine 2009, 27:6662-6668.
5. Ballesteros C., Gortázar C., Canales M., Vicente J., Lasagna A., Gamarra J.A., Carrasco-Garcia R., de la Fuente J. Evaluation of baits for oral vaccination of European wild boar piglets. Res. Vet. Sci. 2009, 86:388-393.
6. Ballesteros C., Carrasco-Garcia R., Vicente J., Carrasco J., Lasagna A., de la Fuente J., Gortázar C. Selective piglet feeders improve age-related bait specificity and uptake rate in overabundant Eurasian wild boar populations. Wildlife Res. 2009, 36:203-212.
7. Benévolo-de-Andrade T.C., Monteiro-Maia R., Cosgrove C., Castello-Branco L.R. BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis - review. Mem. I. Oswaldo Cruz 2005, 100:459-465.
8. Buddle B.M., Aldwell F.E., Skinner M.A., de Lisle G.W., Denis M., Vordermeier H.M., Hewinson R.G., Wedlock D.N. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine 2005, 23:3581-3589.
9. Buddle B.M., Aldwell F.E., Keen D.L., Parlane N.A., Hamel K.L., de Lisle G.W. Oral vaccination of brushtail possums with BCG: investigation into factors that influence vaccine efficacy and determination of duration of immunity. N. Z. Vet. J. 2006, 54:224-230.
10. Buddle, B.M., Aldwell, F.E., Corner, L.A.L., 2009. Progress in the development of tuberculosis vaccines for wildlife. CAB Reviews. Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources 4, No. 030, pp. 10.
11. Cai H., Tian X., Hu X.D., Li S.X., Yu D.H., Zhu Y.X. Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection. Vaccine 2005, 23:3887-3895.
12. Cai H., Yu D.H., Hu X.D., Li S.X., Zhu Y.X. A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge. DNA Cell Biol. 2006, 25:438-447.
13. Collins D.M., de Lisle G.W., Aldwell F.E., Buddle B.M. A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection. Vaccine 2007, 25:4659-4664.
14. Corner L.A.L., Buddle B.M. Conjunctival vaccination of the brushtail possum (Trichosurus vulpecula) with bacille Calmette-Guerin. N. Z. Vet. J. 2005, 53:133-136.
15. Corner L.A., Norton S., Buddle B.M., Morris R.S. The efficacy of bacille Calmette-Guerin vaccine in wild brushtail possums (Trichosurus vulpecula). Res. Vet. Sci. 2002, 73:145-152.
16. Corner L.A.L., Costello E., Lesellier S., O'Meara D., Sleeman D.P., Gormley E. Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation of Mycobacterium bovis. I. Pathology and bacteriology. Res. Vet. Sci. 2007, 83:53-62.
17. Corner L.A.L., Costello E., Lesellier S., O'Meara D., Gormley E. Vaccination of European badgers (Meles meles) with BCG by the subcutaneous and mucosal routes induces protective immunity against endobronchial challenge with Mycobacterium bovis. Tuberculosis 2008, 88:601-609.
18. Cousins D.V. Mycobacterium bovis infection and control in domestic livestock. Rev. Sci. Technol. 2001, 20:71-85.
19. Cross M.L., Labes R.E., Young G., Mackintosh C.G. Systemic but not intraintestinal vaccination with BCG reduces the severity of tuberculosis infection in ferrets (Mustela furo). Int. J. Tuberc. Lung Dis. 2000, 4:473-480.
20. Cross M.L., Coughlan Y., Lambeth M.R., Aldwell F.E. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: effect of reducing or eliminating BCG load on cellular immunity. Vaccine 2007, 25:1297-1303.
21. Cross M.L., Henderson R.J., Lambeth M.R., Buddle B.M., Aldwell F.E. Lipid-formulated BCG as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy and palatability to New Zealand possums (Trichosurus vulpecula). J. Wildl. Dis. 2009, 45:754-765.
22. de Lisle G.W., Bengis R.G., Schmitt S.M., O'Brien D.J. Tuberculosis in free-ranging wildlife: detection, diagnosis and management. Rev. Sci. Technol. 2002, 21:317-334.
23. de Vos V., Bengis R.G., Kriek N.P., Michel A., Keet D.F., Raath J.P., Huchzermeyer H.F. The epidemiology of tuberculosis in free-ranging African buffalo (Syncerus caffer) in the Kruger National Park, South Africa. Onderstepoort J. Vet. Res. 2001, 68:119-130.
24. Fine P.E. The BCG story; lessons from the past and implications for the future. Rev. Infect. Dis. 1989, 11(Suppl. 2):S353-S359.
25. Gallagher J., Clifton-Hadley R.S. Tuberculosis in badgers; a review of the disease and its significance for other animals. Res. Vet. Sci. 2000, 69:203-217.
26. Gallagher J., Monies R., Gavier-Widen M., Rule B. Role of infected, non-diseased badgers in the pathogenesis of tuberculosis in the badger. Vet. Rec. 1998, 142:710-714.
27. Goonetilleke N.P., McShane H., Hannan C.M., Anderson R.J., Brookes R.H., Hill A.V. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol. 2003, 171:1602-1609.
28. Gortázar C., Torres M.J., Vicente J., Acevedo P., Reglero M., de la Fuente J., Negro J.J., Aznar-Martín J. Bovine tuberculosis in Donana Biosphere Reserve: the role of wild ungulates as disease reservoirs in the last Iberian lynx strongholds. PLoS ONE 2008, 3:1-8.
29. Griffin J.M., Williams D.H., Kelly G.E., Clegg T.A., O'Boyle I., Collins J.D., More S.J. The impact of badger removal on the control of tuberculosis in cattle herds in Ireland. Prev. Vet. Med. 2005, 67:237-266.
30. Hope J.C., Villarreal-Ramos B. Bovine TB and the development of new vaccines. Comp. Immun. Microbiol. Infect. Dis. 2008, 31:77-100.
31. Jackson R., Cooke M.M., Coleman J.D., Morris R.S. Naturally occurring tuberculosis caused by Mycobacterium bovis in brushtail possums (Trichosurus vulpecula). I. An epidemiological analysis of lesion distribution. N. Z. Vet. J. 1995, 43:306-314.
32. Jenkins H.E., Morrison W.I., Cox D.R., Donnelly C.A., Johnston W.T., Bourne F.J., Clifton-Hadley R.S., Gettinby G., McInerney J.P., Watkins G.H., Woodroffe R. The prevalence, distribution and severity of detectable pathological lesions in badgers naturally infected with Mycobacterium bovis. Epidemiol. Infect. 2008, 136:1350-1361.
33. Kaufmann S.H.E. Envisioning future strategies for vaccination against tuberculosis. Nat. Rev. Immunol. 2006, 6:699-704.
34. Khare S., Hondalus M.K., Nunes J., Bloom B.R., Adams L.G. Mycobacterium bovis Delta leuD auxotroph-induced protective immunity against tissue colonization, burden and distribution in cattle intranasally challenged with Mycobacterium bovis Ravenel S. Vaccine 2007, 25:1743-1755.
35. Lesellier S., Palmer S., Dalley D.J., Dave D., Johnson L., Hewinson R.G., Chambers M.A. The safety and immunogenicity of Bacillus Calmette-Guerin (BCG) vaccine in European badgers (Meles meles). Vet. Immunol. Immunopathol. 2006, 112:24-37.
36. Livingstone P.G., Ryan T.J., Hancox N.G., Crews K.B., Bosson M.A., Knowles G.J., McCook W. Regionalization: a strategy that will assist with bovine tuberculosis control and facilitate trade. Vet. Microbiol. 2006, 112:291-301.
37. Lopez-Valencia G., Renteria-Evangelista T., de Jesús Williams J., Licea-Navarro A., De la Mora-Valle A., Medina-Basulto G. Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis. Res. Vet. Sci. 2010, 88:44-49.
38. Mahmood K.H., Rook G.A., Stanford J.L., Stuart F.A., Pritchard D.G. The immunological consequences of challenge with bovine tubercle bacilli in badgers (Meles meles). Epidemiol. Infect. 1987, 98:155-163.
39. Martín-Hernando M.P., Höfle U., Vicente J., Ruiz-Fons F., Vidal D., Barral M., Garrido J.M., de la Fuente J., Gortázar C. Lesions associated with Mycobacterium tuberculosis complex infection in European wild boar. Tuberculosis 2007, 87:360-367.
40. Maue A.C., Waters W.R., Palmer M.V., Whipple D.L., Minion F.C., Brown W.C., Estes D.M. CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis. Vaccine 2004, 23:769-779.
41. Maue A.C., Waters W.R., Palmer M.V., Nonnecke B.J., Minion F.C., Brown W.C., Norimine J., Foote M.R., Schererm C.F.C., Estes D.M. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 2007, 25:4735-4746.
42. McNair J., Welsh M.D., Pollock J.M. The immunology of bovine tuberculosis and progression toward improved disease control strategies. Vaccine 2007, 25:5504-5511.
43. Michel A.L., Bengis R.G., Keet D.F., Hofmeyr M., de Klerk L.M., Cross P.C., Jolles A.E., Cooper D., Whyte I.J., Buss P., Godfroid J. Wildlife tuberculosis in South African conservation areas: implications and challenges. Vet. Microbiol. 2006, 112:91-100.
44. Murphy D., Corner L.A.L., Gormley E. Adverse reactions to Mycobacterium bovis bacilli Calmette Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species. Tuberculosis 2008, 88:344-357.
45. Naranjo V., Gortázar C., Vicente J., de la Fuente J. Evidence of the role of European wild boar as a reservoir of Mycobacterium tuberculosis complex. Vet. Microbiol. 2008, 127:1-9.
46. Nishi J.S., Shury T., Elkin B.T. Wildlife reservoirs for bovine tuberculosis (Mycobacterium bovis) in Canada: strategies for management and research. Vet. Microbiol. 2006, 112:325-338.
47. Nol P., Palmer M.V., Waters W.R., Aldwell F.E., Buddle B.M., Triantis J., Linke L., Phillips G., Thacker T., Rhyan J., Dunbar M., Salman M.D. Efficacy of oral and parenteral routes of Mycobacterium bovis bacille Calmette-Guerin vaccination against experimental bovine tuberculosis in white-tailed deer (Odocoileus virginianus): a feasibility study. J. Wildl. Dis 2008, 44:247-259.
48. O'Brien D.J., Schmitt S.M., Fitzgerald S.D., Berry D.E., Hickling G.J. Managing the wildlife reservoir of Mycobacterium bovis: the Michigan, USA, experience. Vet. Microbiol. 2006, 112:313-323.
49. Orme I. Adaptive immunity to mycobacteria. Curr. Opin. Microbiol. 2004, 7:58-61.
50. Palmer M.V., Whipple D.L., Olsen S.C. Development of a model of natural infection with Mycobacterium bovis in white-tailed deer. J. Wildl. Dis. 1999, 35:450-457.
51. Palmer, M.V., Thacker, T.C., Waters, W.R., 2009. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with M. bovis. Zoonoses Publ. Health 56, 243-251.
52. Parlane N.A., Wedlock D.N., Buddle B.M., Rehm B.H.A. Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents. Appl. Environ. Microbiol. 2009, 75:7739-7744.
53. Qureshi T., Labes R.E., Cross M.L., Mackintosh C.G. Partial protection against oral challenge with Mycobacterium bovis in ferrets (Mustela furo) following oral vaccination with BCG. Int. J. Tuberc. Lung Dis. 1999, 3:1025-1033.
54. Santosuosso M., McCormick S., Zhang X., Zangiacz A., Xing Z. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun. 2006, 74:4634-4643.
55. Skinner M.A., Wedlock D.N., Buddle B.M. Vaccination of animals against Mycobacterium bovis. Rev. Sci. Technol. 2001, 20:112-132.
56. Skinner M.A., Buddle B.M., Wedlock D.N., Keen D.L., de Lisle G.W., Tascon R.E., Ferraz J.C., Lowrie D.B., Cockle P.J., Vordermeier H.M., Hewinson R.G. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy in cattle induces protection against bovine tuberculosis. Infect. Immun. 2003, 71:4901-4907.
57. Skinner M.A., Wedlock D.N., de Lisle G.W., Cooke M.M., Tascon R.E., Ferraz J.C., Lowrie D.B., Vordermeier H.M., Hewinson R.G., Buddle B.M. The order of a prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70 and Apa is not critical for enhancing protection against bovine tuberculosis. Infect. Immun. 2005, 73:4441-4444.
58. Steele J.H. Regional and Country Status Report. Mycobacterium bovis Infection in Animals and Humans 1995, 169-172. Iowa Press, Ames. C.O. Thoen, J.H. Steele (Eds.).
59. Stuart F.A., Mahmood K.H., Stanford J.L., Prichard D.G. Development of diagnostic tests for, and vaccination against, tuberculosis in badgers. Mammal. Rev. 1988, 18:74-75.
60. Tompkins D.M., Ramsey D.S.L., Cross M.L., Aldwell F.E., de Lisle G.W., Buddle B.M. Oral vaccination reduces the incidence of bovine tuberculosis in a free-living wildlife species. Proc. R. Soc. B: Biol. Sci. 2009, 276:2987-2995.
61. Vordermeier H.M., Whelan A., Cockle P.J., Farrant L., Palmer N., Hewinson R.G. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol. 2001, 8:571-578.
62. Vordermeier H.M., Rhodes S.G., Dean G., Goonetilleke N., Huygen K., Hill A.V., Hewinson R.G., Gilbert S.C. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 2004, 112:461-470.
63. Vordermeier H.M., Huygen K., Singh M., Hewinson R.G., Xing Z. Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing mycobacterial antigen 85A and Mycobacterium bovis BCG. Infect. Immun. 2006, 74:1416-1418.
64. Vordermeier H.M., Hewinson R.G. Development of cattle TB vaccines in the UK. Vet. Immunol. Immunopathol. 2006, 112:38-48.
65. Vordermeier H.M., Villaraeal-Ramos B., Cockle P.J., McAulay M., Rhodes S.G., Thacker T., Gilbert S.C., McShane H., Hill A.V.S., Xing Z., Hewinson R.G. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 2009, 77:3364-3373.
66. Waters W.R., Palmer M.V., Nonnecke B.J., Thacker T.C., Capinos Scherer C.F., Estes D.M., Jacobs W.R., Glatman-Freedman A., Larsen M.H. Failure of a Mycobacterium tuberculosis ΔRD1ΔpanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elecited by M. bovis bacille Calmette Guerin. Vaccine 2007, 25:7832-7840.
67. Waters W.R., Palmer M.V., Nonnecke B.J., Thacker T.C., Capinos Scherer C.F., Estes D.M., Hewinson R.G., Vordermeier H.M., Barnes S.W., Federe G.C., Walker J.R., Glynne R.J., Hsu T., Weinrick B., Biermann K., Larsen M.H., Jacobs W.R. Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves. Vaccine 2009, 27:1201-1209.
68. Wedlock D.N., Skinner M.A., Parlane N.A., Vordermeier H.M., Hewinson R.G., de Lisle G.W., Buddle B.M. Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis. Tuberculosis 2003, 83:339-349.
69. Wedlock D.N., Skinner M.A., Vordermeier H.M., Hewinson R.G., Hecker R., van Drunen Littel-van den Hurk S., Buddle B.M. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 2005, 106:53-63.
70. Wedlock D.N., Denis M., Skinner M.A., Koach J., de Lisle G.W., Vordermeier H.M., Hewinson R.G., van Drunen Littel-van den Hurk S., Babiuk L.A., Hecker R., Buddle B.M. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to vaccination with BCG alone. Infect. Immun. 2005, 73:3540-3546.
71. Wedlock D.N., Aldwell F.E., Keen D.L., Skinner M.A., Buddle B.M. Oral vaccination of brushtail possums (Trichosurus vulpecula) with BCG: immune responses, persistence of BCG in lymphoid organs and excretion in faeces. N. Z. Vet. J. 2005, 53:301-306.
72. Wedlock D.N., Denis M., Painter G.F., Ainge G.D., Vordermeier H.M., Hewinson R.G., Buddle B.M. Enhanced protection against bovine tuberculosis after coadministration Mycobacterium bovis BCG and a mycobacterial protein vaccine-adjuvant combination, but not after coadministration of adjuvant alone. Clin. Vacc. Immunol. 2008, 15:765-772.